Total Payments
$2,057
2023 Payments
$47.47
Companies
21
Transactions
160
Medicare Patients
376
Medicare Billing
$48,572
Payment Breakdown by Category
Food & Beverage$2,042 (99.2%)
Education$15.45 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,042 | 157 | 99.2% |
| Education | $15.45 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $366.62 | 21 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $329.75 | 34 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $214.96 | 16 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $172.54 | 15 | $0 (2020) |
| Allergan, Inc. | $135.02 | 17 | $0 (2020) |
| Vanda Pharmaceuticals Inc. | $120.24 | 8 | $0 (2021) |
| Lundbeck LLC | $112.62 | 7 | $0 (2020) |
| Alkermes, Inc. | $112.18 | 7 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $101.01 | 10 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $78.70 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $47.47 | 2 | AbbVie Inc. ($47.47) |
| 2022 | $45.55 | 3 | ABBVIE INC. ($26.07) |
| 2021 | $437.70 | 24 | AbbVie Inc. ($293.08) |
| 2020 | $235.64 | 16 | Otsuka America Pharmaceutical, Inc. ($56.55) |
| 2019 | $1,164 | 105 | Otsuka America Pharmaceutical, Inc. ($209.99) |
| 2018 | $126.23 | 10 | Otsuka America Pharmaceutical, Inc. ($63.21) |
All Payment Transactions
160 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2022 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: ADHD | ||||||
| 09/22/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: NEUROSCIENCE | ||||||
| 01/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2021 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/02/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $22.40 | General |
| Category: PSYCHOLOGY | ||||||
| 10/19/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: CNS | ||||||
| 10/19/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $23.80 | General |
| Category: PSYCHOLOGY | ||||||
| 10/19/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: NEUROSCIENCE | ||||||
| 08/25/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.22 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 68 | 186 | $39,130 | $12,440 |
| 2022 | 2 | 80 | 155 | $33,355 | $8,792 |
| 2021 | 2 | 87 | 139 | $30,485 | $10,457 |
| 2020 | 4 | 141 | 344 | $57,955 | $16,883 |
Total Patients
376
Total Services
824
Medicare Billing
$48,572
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 94 | $23,030 | $8,025 | 34.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 34 | 92 | $16,100 | $4,414 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 89 | $21,805 | $5,682 | 26.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 39 | 66 | $11,550 | $3,110 | 26.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 88 | $21,560 | $8,259 | 38.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 51 | $8,925 | $2,198 | 24.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 52 | 232 | $40,600 | $11,767 | 29.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 63 | 83 | $8,300 | $2,634 | 31.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 15 | 15 | $5,625 | $1,359 | 24.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 14 | $3,430 | $1,124 | 32.8% |
About Dr. Thripura Thirtala, M.D
Dr. Thripura Thirtala, M.D is a Psychiatry healthcare provider based in Saint Peters, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2014. The National Provider Identifier (NPI) number assigned to this provider is 1356757116.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thripura Thirtala, M.D has received a total of $2,057 in payments from pharmaceutical and medical device companies, with $47.47 received in 2023. These payments were reported across 160 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,042).
As a Medicare-enrolled provider, Thirtala has provided services to 376 Medicare beneficiaries, totaling 824 services with total Medicare billing of $48,572. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Saint Peters, MO
- Active Since 07/01/2014
- Last Updated 08/10/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1356757116
Products in Payments
- VRAYLAR (Drug) $501.64
- REXULTI (Drug) $268.38
- LATUDA (Drug) $214.96
- ABILIFY MAINTENA (Drug) $154.58
- SPRAVATO (Drug) $120.05
- ARISTADA (Drug) $112.18
- Fanapt (Drug) $86.20
- INGREZZA (Drug) $78.70
- Trintellix (Drug) $59.74
- INVEGA SUSTENNA (Drug) $52.49
- QELBREE (Drug) $46.20
- Adzenys XR-ODT (Drug) $45.77
- VYVANSE (Drug) $43.90
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $43.86
- CAPLYTA (Drug) $36.06
- HETLIOZ (Drug) $34.04
- TRINTELLIX (Drug) $28.60
- AUSTEDO (Drug) $28.57
- Zubsolv (Drug) $23.20
- Dyanavel XR (Drug) $19.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Saint Peters
Satish Kulkarni, Md, MD
Psychiatry — Payments: $19,489
Psychiatry $19,489
Dr. Chinya Murali, Md, MD
Psychiatry — Payments: $8,299
Psychiatry $8,299
Dr. Roomana Arain, M.d, M.D
Psychiatry — Payments: $3,993
Psychiatry $3,993
Dr. Raafea Malik, M.d, M.D
Psychiatry — Payments: $2,123
Psychiatry $2,123
Srinivas Battula, Md, MD
Psychiatry — Payments: $718.20
Psychiatry $718.20
Dawn Holemon, M.d, M.D
Psychiatry — Payments: $191.24
Psychiatry $191.24